Anticalins in Drug Development

ISSN： 1173-8804

Source： BioDrugs, Vol.19, Iss.5, 2005-01, pp. : 279-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aptamers in Research and Drug Development

By Günter Mayer Andreas Jenne

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Clinical Trial Simulation in Drug Development

By Girard Pascal

Therapie, Vol. 59, Iss. 3, 2004-01 ,pp. : 297-304

Adis International

Access to resources Recommend Favorite

Pharmacogenetic and Pharmacogenomic Studies: Impact on Drug Discovery and Drug Development

By Alhenc-Gelas François

Therapie, Vol. 58, Iss. 3, 2003-01 ,pp. : 279-282

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies: Concepts and Lessons for Drug Development

By Mould Diane R. Green Bruce

BioDrugs, Vol. 24, Iss. 1, 2010-02 ,pp. : 23-39

Adis International

Access to resources Recommend Favorite

Recombinant Drug Development, Regulation, and Commercialization: An Indian Industry Perspective

By Sahoo Niharika Manchikanti Padmavati

BioDrugs, Vol. 25, Iss. 2, 2011-04 ,pp. : 105-113

Adis International

Access to resources Recommend Favorite